Oliger Christy J.
Insider CIK 1822092 · SRRA Director · RETA Director · KPTI Director · REPL Director · RYZB Director · VERA Director · LVTX Director · NUVL Director · ZBIO Director · BCAX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2026-09-01 | 2026-09-02 | 37,000 | — | $0 | 37,000 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2026-09-01 | 2026-09-02 | 37,000 | — | $0 | 37,000 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2026-07-28 | 2026-07-29 | 38,950 | — | $0 | 38,950 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2026-07-28 | 2026-07-29 | 38,950 | — | $0 | 38,950 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 6,119 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | U Tender | 2026-07-15 | 2026-07-15 | 1,324 | $124.00 | $164.2K | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-15 | 6,091 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2026-06-16 | 2026-06-18 | 3,444 | — | $0 | 7,415 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2026-05-21 | 2026-05-26 | 17,084 | — | $0 | 17,084 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2026-05-21 | 2026-05-26 | 15,508 | — | $0 | 15,508 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2026-04-01 | 2026-04-07 | 44,500 | — | $0 | 44,500 | SEC↗ |
| LVTX LAVA Therapeutics NV | D To issuer deriv | 2025-11-13 | 2025-11-17 | 33,390 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 6,119 | — | $0 | 6,119 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2025-06-18 | 2025-06-20 | 3,971 | — | $0 | 3,971 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2025-05-28 | 2025-05-29 | 4,600 | — | $0 | 4,600 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2025-05-14 | 2025-05-16 | 14,000 | — | $0 | 14,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2025-04-01 | 2025-04-03 | 32,000 | — | $0 | 32,000 | SEC↗ |
| LVTX LAVA Therapeutics NV | A Award deriv | 2025-02-13 | 2025-02-18 | 33,390 | — | $0 | 33,390 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2024-05-29 | 2024-05-30 | 69,000 | — | $0 | 69,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 32,000 | — | $0 | 32,000 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer deriv | 2024-02-26 | 2024-02-27 | 114,579 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 10,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 1,250 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 180 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 2,137 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 106 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 5,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 5,620 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 5,565 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 2,137 | — | $0 | 2,137 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-06-07 | 2023-06-09 | 1,682 | $93.61 | $157.5K | 5,565 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2023-05-24 | 2023-05-25 | 34,000 | — | $0 | 34,000 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2023-04-01 | 2023-04-04 | 25,200 | — | $0 | 25,200 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 18,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-09 | 5,620 | — | $0 | 5,620 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-06-08 | 2022-06-09 | 3,883 | $34.76 | $135.0K | 3,883 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-05-19 | 2022-05-20 | 23,900 | — | $0 | 23,900 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2022-04-01 | 2022-04-05 | 16,500 | — | $0 | 16,500 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2021-12-01 | 2021-12-03 | 33,000 | — | $0 | 33,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-06-10 | 2021-06-14 | 180 | $83.24 | $15.0K | 180 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-06-10 | 2021-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 18,000 | — | $0 | 18,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-05-21 | 2021-05-21 | 23,900 | — | $0 | 23,900 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-04-15 | 2021-04-16 | 106 | $52.85 | $5.6K | 106 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-04-15 | 2021-04-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-04-15 | 2021-04-16 | 1,250 | — | $0 | 1,250 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-08-28 | 2020-08-31 | 32,800 | — | $0 | 32,800 | SEC↗ |